Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology ( ACR ) Convergence Meeting

Benzinga
2025.10.22 14:38
portai
I'm PortAI, I can summarize articles.

南舊金山，加利福尼亞州，2025 年 10 月 22 日（GLOBE NEWSWIRE）-- Nkarta, Inc.（納斯達克股票代碼：NKTX），一家臨牀階段的生物製藥公司，正在開發工程化自然殺傷（NK）細胞療法以治療自身免疫疾病，今天宣佈將於本週日於芝加哥展示一份海報……

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.